| | | | | InnerCool Therapies is a leader in the field of therapeutic hypothermia, the practice of altering body temperature to preserve tissue and improve patient outcomes. A growing base of clinical research shows that the rapid induction of mild hypothermia (33°C - 34°C) during periods of ischemia can protect tissue from damage. Furthermore, recent studies have shown that the earlier cooling is achieved in the setting of ischemia and reperfusion, the better the outcome.(1,2,3,4) With the acquisition of InnerCool Therapies, Philips will advance its leading presence in the rapidly changing field of emergency care and become the only company that offers a comprehensive suite of both surface (external) and endovascular (internal) body temperature management solutions. InnerCool currently offers clinicians the first complete continuum of Therapeutic Hypothermia products - from endovascular systems which rapidly cool and gradually or rapidly re-warm patients, to an innovative surface-based cooling and warming system, providing unsurpassed flexibility for treating a range of patients with complex needs. |
| About the CoolBlue™ Surface Pad System |
| InnerCool's CoolBlue™ is a non-invasive surface-based cooling and warming system that includes a console and a disposable CoolBlue vest with upper thigh pads. It is designed for use for patients who need temperature management and may be used for prolonged periods of time. The system consists of non-invasive surface pads that are applied to the patient's torso and upper thighs and connected to a console. The console regulates water circulation through the pads to achieve and maintain desired patient temperature. The system can be initiated in the emergency room or intensive care unit by nurse or other trained clinician The CoolBlue™ pads are easy to place on patients and remove if necessary No adhesives contact the skin so allergic reactions and skin irritation is not a factor Suitable for prolonged uses such as fever management Warms as well as cools Covers approximately 40% of the patient's body surface area for effective patient cooling Unique pad design enables excellent patient access without the need to remove pads
|
| The CoolBlue™ Console features: |
| | About the RapidBlue™ Endovascular System |
| InnerCool’s RapidBlue™ is a high-performance endovascular temperature management system that automatically cools or warms the patient as necessary to maintain desired body temperature. It includes a programmable console with an intuitive user interface and a catheter designed to quickly modulate patient temperature. It offers one of the fastest cooling and warming times of any temperature management therapy currently on the market. The console can be used with InnerCool's Standard and Accutrol™ catheters to quickly modulate patient temperature in association with surgery or other medical procedures, and provides rapid temperature management for ALL patient sizes. Its closed loop system modulates whole body temperature without fluid introduction or exchange by circulating cool or warm saline. Cooling rates of approximately 4°C/hr (4) Warming rates of approximately 2°C/hr (4) Gradual warming can be programmed Excellent safety profile in part due to optically induced heparin-bonded catheter which reduces chances for DVTs (2) Head-MRI compatible Accutrol Integrated Temperature Sensor eliminates the need for slow-to-react bladder or rectal probes and provides “soft-landing” at desired target temperature Powerful enough to minimize the use of paralytic agents (3,4) Rapidly cools awake patients (4)
|
| The RapidBlue™ Console features: |
| Easy-to-use integrated cassette which shortens set-up time User-friendly graphic interface with touch-panel screen Compatibility with standard or Accutrol™ catheters
|
| | InnerCool offers two catheters: the standard model and the Accutrol™. Accutrol™ is the only catheter that contains an integrated temperature sensor. It can measure the patient's core body temperature within 0.1°C of pulmonary artery temperature. The Accutrol™ catheter eliminates the need to place bladder or rectal probes, which can be slow to react to actual decreases in core body temperature, uncomfortable to the patient and time-consuming to place. Low profile of 10.7F and 14F reduces the likelihood of vessel damage and flow-restriction unlike balloon-based cooling systems which can expand to outer diameters of 24F to 47F during use Can be used in an ER, OR or ICU setting without the need for continuous fluoroscopy Covalently heparin bonded coating enhances hemocompatibility Provides thermo-conductance of metal with conventional catheter flexibility InnerCool's standard catheter incorporates the same design and performance features as the Accutrol™ catheter. However, an external core temperature feedback probe is required.
|
| | 1. Hypothermia After Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med. 2002;346:549-556.
2. Bernard SA, et al. Treatment of comatose survivors of out-of-hospitals cardiac arrest with induced hypothermia. N Eng J Med. 2002;346:557-563.
3. Holzer M, Müllner M, Sterz F, et al. Efficacy and safety of endovascular cooling after cardiac arrest: cohort study and Bayesian approach. Stroke. 2006;37:1792-1797.
4. Steinberg GK, Ogilvy CS, Shuer LM et al. Comparison of endovascular and surface cooling during unruptured cerebral aneurysm repair. Neurosurgery. 2004;55:307-315. |
| For further information, please contact: |
| | About Royal Philips Electronics |
| Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a diversified Health and Well-being company, focused on improving people’s lives through timely innovations. As a world leader in healthcare, lifestyle and lighting, Philips integrates technologies and design into people-centric solutions, based on fundamental customer insights and the brand promise of “sense and simplicity”. Headquartered in the Netherlands, Philips employs approximately 116,000 employees in more than 60 countries worldwide. With sales of EUR 26 billion in 2008, the company is a market leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as lifestyle products for personal well-being and pleasure with strong leadership positions in flat TV, male shaving and grooming, portable entertainment and oral healthcare. News from Philips is located at www.philips.com/newscenter. |
|
|
| | | | |
|
|
|